000 | 02036nam a22004575i 4500 | ||
---|---|---|---|
001 | u374492 | ||
003 | SIRSI | ||
005 | 20160812084237.0 | ||
007 | cr nn 008mamaa | ||
008 | 100927s2011 gw | s |||| 0|eng d | ||
020 |
_a9783642134432 _9978-3-642-13443-2 |
||
040 | _cMX-MeUAM | ||
050 | 4 | _aRM1-950 | |
082 | 0 | 4 |
_a615 _223 |
100 | 1 |
_aFredholm, Bertil B. _eauthor. |
|
245 | 1 | 0 |
_aMethylxanthines _h[recurso electrónico] / _cby Bertil B. Fredholm. |
264 | 1 |
_aBerlin, Heidelberg : _bSpringer Berlin Heidelberg : _bImprint: Springer, _c2011. |
|
300 |
_aXV, 559p. 6 illus., 4 illus. in color. _bonline resource. |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_atext file _bPDF _2rda |
||
490 | 1 |
_aHandbook of Experimental Pharmacology, _x0171-2004 ; _v200 |
|
520 | _aIn the present volume of the Handbook of Experimental Pharmacology well known experts describe the actions of different xanthines with a focus on caffeine and theophylline. A special chapter is devoted to theobromine, an active component of chocolate, the actions of which are less well characterized. This book also presents the pharmacology of one xanthine derivative, propentofylline, as an example of a xanthine that has gone through extensive development for a novel therapeutic area. | ||
650 | 0 | _aMedicine. | |
650 | 0 | _aNeurochemistry. | |
650 | 0 | _aToxicology. | |
650 | 0 | _aBiochemistry. | |
650 | 1 | 4 | _aBiomedicine. |
650 | 2 | 4 | _aPharmacology/Toxicology. |
650 | 2 | 4 | _aNeurochemistry. |
650 | 2 | 4 | _aMedical Biochemistry. |
710 | 2 | _aSpringerLink (Online service) | |
773 | 0 | _tSpringer eBooks | |
776 | 0 | 8 |
_iPrinted edition: _z9783642134425 |
830 | 0 |
_aHandbook of Experimental Pharmacology, _x0171-2004 ; _v200 |
|
856 | 4 | 0 |
_zLibro electrónico _uhttp://148.231.10.114:2048/login?url=http://link.springer.com/book/10.1007/978-3-642-13443-2 |
596 | _a19 | ||
942 | _cLIBRO_ELEC | ||
999 |
_c202372 _d202372 |